Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Aston University and pharmaceutical giant sign for medical future of Midlands

11.10.2004


Aston University in Birmingham, UK has just signed a long-term agreement with pharmaceutical manufacturing giant, Mayne Pharma Plc , to run the first dedicated medical manufacturing clean room in the region.



The room will be used to produce specialist cancer and other drugs and make them available across the Midlands. This will address the particular need in the region for aseptic facilities to support the preparation of pharmaceuticals with a short shelf life - particularly in the treatment of children. In addition to this, the agreement - which was facilitated by Aston University’s Business Partnership Unit – will also create a unique opportunity for the West Midlands.

Guppy Dhariwal, Director of Finance and Business Services at Aston stated: “Aston University is delighted to be entering into this exciting new partnership. It will not only create new jobs in the region but it will, to the best of our knowledge, be the first manufacturing unit of its type that brings together high-quality university research with advanced pharmaceutical manufacturing techniques.”


The alliance will offer Aston University (which boasts the only pharmacy school in the region) and Mayne Pharma numerous collaborative opportunities, and will contribute directly to the University’s research and teaching in pharmacy.

John Edwards Chief Executive of Advantage West Midlands said: “Medical technologies is a growth industry in this region and we’re delighted to support Aston University in this exciting venture.”

The clean room provides an ultra clean, sterile and controlled environment for pharmaceutical manufacture, research and teaching and will offer a complete specialist environment to support the development of new medicines. Its rooms are temperature and humidity controlled to allow the aseptic production, manipulation and reconstitution of a variety of medical products (including chemotherapy drugs usually used in the treatment of cancer and individually tailored treatments for premature babies) that cannot be sterilised commercially.

Scott Richards, President, Mayne Pharma EMEA, said: “This is an important development for growing Mayne’s aseptic manufacturing business operations in the UK. Being located at such a research-focussed university as Aston in Birmingham, and so close to excellent transport links will enable us to offer outstanding levels of service for our customers in the Midlands whilst also supporting our wider UK business.”

Paul Burkwood | alfa
Further information:
http://www.aston.ac.uk

More articles from Life Sciences:

nachricht 'Y' a protein unicorn might matter in glaucoma
23.10.2017 | Georgia Institute of Technology

nachricht Microfluidics probe 'cholesterol' of the oil industry
23.10.2017 | Rice University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>